SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001477932-21-001169
Filing Date
2021-03-02
Accepted
2021-03-02 15:26:40
Documents
1
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 5581
  Complete submission text file 0001477932-21-001169.txt   7137
Mailing Address 333 SOUTH GRAND AVENUE, 18TH FLOOR LOS ANGELES CA 90071
Business Address
GALLIGAN JOSEPH J (Reporting) CIK: 0001198613 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54208 | Film No.: 21703131

Mailing Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806
Business Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806 (714) 462-4880
BioCorRx Inc. (Issuer) CIK: 0001443863 (see all company filings)

IRS No.: 900967447 | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC